Investing in early-stage stem cell therapy developers

Stijn Heessen, Kristian Tryggvason

21 February 2025

Viewpoint

Advancing mRNA-based cell therapies: the crucial role of mRNA optimization for therapeutic efficacy

Christian Bär, Ulrich Blache, Sandy Tretbar

23 January 2025

Viewpoint

Efficient non-viral engineering of immune cells for cell therapy using circular single-stranded DNA

Hao Wu

13 January 2025

Viewpoint

Bio-printing in the context of end-to-end scalable tissue-engineered ATMP manufacturing

Isaak Decoene, Ioannis Papantoniou

12 December 2024

Viewpoint

Industrializing cell therapy: how to bring curative therapies to all patients who need them?

Jens Vogel

20 November 2024

Viewpoint

Overcoming the senescence barrier in stem cell expansion

William Ying Khee Hwang

14 November 2024

Viewpoint

Gene delivery: persistent challenges call for a reference measure

Max Ryadnov

22 October 2024

Viewpoint

Decentralizing gene and cell therapy manufacturing: changing tides or uphill battle

Magdi Elsallab

04 October 2024

Viewpoint

Pioneering the future of non-viral genome engineering

Hao Wu

18 September 2024

Viewpoint

Cellular immunotherapy—a matter of delivery?

Nina Bauer

05 September 2024

Viewpoint

A pathway forward for CAR-NK cell therapy

Scott McComb

06 August 2024

Viewpoint

Expanding the therapeutic index of lipid nanoparticles: potential key for clinical translation success

Zhenghong Gao

12 June 2024

Viewpoint

Swiss regulatory aspects and evaluation considerations for ATMPs and other nucleic acid-based products such as mRNA-based vaccines

Julia Djonova

15 May 2024

Viewpoint

Enabling affordable access to CAR-T cell and other cellular gene therapy products

R Orentas, Y Xiong, I Oparaocha et al

13 May 2024

Viewpoint

Best practices and considerations for outsourcing with CDMOs

Joseph W Graskemper

11 April 2024

Viewpoint

Regulatory strategies for developing and manufacturing RNA-LNPs

Alexander Aust

05 April 2024

Viewpoint

Human capital comes with a memory

Helena Strigard

25 March 2024

Viewpoint

2024: the year of the genome editing technologies?

Harriet Edwards

25 March 2024

Viewpoint

Regulatory and scientific considerations for building translational cell and gene therapy packages

Shannon Dahl

23 February 2024

Viewpoint

The evolving realm of nucleic acids: past, present, and future

Chris Mason

22 February 2024

Viewpoint

Autologous induced pluripotent stem cell (iPSC)-derived therapies: a realistic solution for advancing regenerative medicine

Jarett Anderson, Timothy Nelson

17 January 2024

Viewpoint